BIOVENTUS INC - A (BVS) Fundamental Analysis & Valuation

NASDAQ:BVS • US09075A1088

Current stock price

8.94 USD
-0.32 (-3.46%)
At close:
8.94 USD
0 (0%)
After Hours:

This BVS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. BVS Profitability Analysis

1.1 Basic Checks

  • In the past year BVS was profitable.
  • BVS had a positive operating cash flow in the past year.
  • In multiple years BVS reported negative net income over the last 5 years.
  • BVS had a positive operating cash flow in 4 of the past 5 years.
BVS Yearly Net Income VS EBIT VS OCF VS FCFBVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M -150M

1.2 Ratios

  • The Return On Assets of BVS (3.33%) is better than 79.26% of its industry peers.
  • BVS has a better Return On Equity (12.35%) than 87.23% of its industry peers.
  • BVS has a better Return On Invested Capital (8.50%) than 84.57% of its industry peers.
  • BVS had an Average Return On Invested Capital over the past 3 years of 3.98%. This is significantly below the industry average of 9.31%.
  • The last Return On Invested Capital (8.50%) for BVS is above the 3 year average (3.98%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.33%
ROE 12.35%
ROIC 8.5%
ROA(3y)-6.97%
ROA(5y)-6.18%
ROE(3y)-34.02%
ROE(5y)-29.59%
ROIC(3y)3.98%
ROIC(5y)N/A
BVS Yearly ROA, ROE, ROICBVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • Looking at the Profit Margin, with a value of 4.00%, BVS is in the better half of the industry, outperforming 75.53% of the companies in the same industry.
  • In the last couple of years the Profit Margin of BVS has grown nicely.
  • With a decent Operating Margin value of 9.91%, BVS is doing good in the industry, outperforming 78.19% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BVS has grown nicely.
  • BVS has a better Gross Margin (68.33%) than 76.06% of its industry peers.
  • In the last couple of years the Gross Margin of BVS has remained more or less at the same level.
Industry RankSector Rank
OM 9.91%
PM (TTM) 4%
GM 68.33%
OM growth 3YN/A
OM growth 5Y3.04%
PM growth 3YN/A
PM growth 5Y23.91%
GM growth 3Y1.86%
GM growth 5Y-1.23%
BVS Yearly Profit, Operating, Gross MarginsBVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. BVS Health Analysis

2.1 Basic Checks

  • BVS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for BVS has been reduced compared to 1 year ago.
  • Compared to 5 years ago, BVS has more shares outstanding
  • BVS has a better debt/assets ratio than last year.
BVS Yearly Shares OutstandingBVS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
BVS Yearly Total Debt VS Total AssetsBVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • BVS has an Altman-Z score of 1.51. This is a bad value and indicates that BVS is not financially healthy and even has some risk of bankruptcy.
  • BVS has a Altman-Z score (1.51) which is in line with its industry peers.
  • The Debt to FCF ratio of BVS is 4.21, which is a neutral value as it means it would take BVS, 4.21 years of fcf income to pay off all of its debts.
  • BVS has a Debt to FCF ratio of 4.21. This is in the better half of the industry: BVS outperforms 79.26% of its industry peers.
  • BVS has a Debt/Equity ratio of 1.56. This is a high value indicating a heavy dependency on external financing.
  • BVS has a Debt to Equity ratio of 1.56. This is in the lower half of the industry: BVS underperforms 79.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF 4.21
Altman-Z 1.51
ROIC/WACC0.78
WACC10.89%
BVS Yearly LT Debt VS Equity VS FCFBVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 1.70 indicates that BVS should not have too much problems paying its short term obligations.
  • BVS has a worse Current ratio (1.70) than 69.15% of its industry peers.
  • BVS has a Quick Ratio of 1.19. This is a normal value and indicates that BVS is financially healthy and should not expect problems in meeting its short term obligations.
  • BVS has a Quick ratio of 1.19. This is in the lower half of the industry: BVS underperforms 69.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.19
BVS Yearly Current Assets VS Current LiabilitesBVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. BVS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 44.68% over the past year.
  • BVS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.76% yearly.
  • The Revenue has decreased by -0.91% in the past year.
  • Measured over the past years, BVS shows a quite strong growth in Revenue. The Revenue has been growing by 12.08% on average per year.
EPS 1Y (TTM)44.68%
EPS 3Y61.98%
EPS 5Y32.76%
EPS Q2Q%60%
Revenue 1Y (TTM)-0.91%
Revenue growth 3Y3.52%
Revenue growth 5Y12.08%
Sales Q2Q%2.77%

3.2 Future

  • Based on estimates for the next years, BVS will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.25% on average per year.
  • Based on estimates for the next years, BVS will show a small growth in Revenue. The Revenue will grow by 6.77% on average per year.
EPS Next Y14.86%
EPS Next 2Y14.11%
EPS Next 3YN/A
EPS Next 5Y12.25%
Revenue Next Year6.8%
Revenue Next 2Y6.7%
Revenue Next 3Y6.7%
Revenue Next 5Y6.77%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BVS Yearly Revenue VS EstimatesBVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
BVS Yearly EPS VS EstimatesBVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 0 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

8

4. BVS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 13.15 indicates a correct valuation of BVS.
  • Based on the Price/Earnings ratio, BVS is valued cheaply inside the industry as 88.83% of the companies are valued more expensively.
  • BVS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.89.
  • With a Price/Forward Earnings ratio of 11.45, the valuation of BVS can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BVS indicates a rather cheap valuation: BVS is cheaper than 90.96% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.19. BVS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.15
Fwd PE 11.45
BVS Price Earnings VS Forward Price EarningsBVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BVS is valued cheaper than 92.55% of the companies in the same industry.
  • 97.87% of the companies in the same industry are more expensive than BVS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 10.31
EV/EBITDA 9.64
BVS Per share dataBVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • BVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of BVS may justify a higher PE ratio.
  • A more expensive valuation may be justified as BVS's earnings are expected to grow with 14.11% in the coming years.
PEG (NY)0.88
PEG (5Y)0.4
EPS Next 2Y14.11%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BVS Dividend Analysis

5.1 Amount

  • No dividends for BVS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BVS Fundamentals: All Metrics, Ratios and Statistics

BIOVENTUS INC - A

NASDAQ:BVS (3/27/2026, 8:03:50 PM)

After market: 8.94 0 (0%)

8.94

-0.32 (-3.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-05
Earnings (Next)05-04
Inst Owners77.64%
Inst Owner Change2.28%
Ins Owners2.61%
Ins Owner Change1.04%
Market Cap743.36M
Revenue(TTM)568.09M
Net Income(TTM)22.73M
Analysts82.5
Price Target15.05 (68.34%)
Short Float %2.44%
Short Ratio4.89
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.41%
Min EPS beat(2)9.67%
Max EPS beat(2)29.14%
EPS beat(4)3
Avg EPS beat(4)69.33%
Min EPS beat(4)-0.99%
Max EPS beat(4)239.51%
EPS beat(8)7
Avg EPS beat(8)103.52%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.15%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)0.96%
Revenue beat(4)2
Avg Revenue beat(4)0.08%
Min Revenue beat(4)-0.67%
Max Revenue beat(4)0.96%
Revenue beat(8)6
Avg Revenue beat(8)3.18%
Revenue beat(12)10
Avg Revenue beat(12)3.35%
Revenue beat(16)11
Avg Revenue beat(16)1.45%
PT rev (1m)1.72%
PT rev (3m)-1.67%
EPS NQ rev (1m)-11.43%
EPS NQ rev (3m)-13.89%
EPS NY rev (1m)-2.73%
EPS NY rev (3m)-2.73%
Revenue NQ rev (1m)-1.22%
Revenue NQ rev (3m)-1.59%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-0.46%
Valuation
Industry RankSector Rank
PE 13.15
Fwd PE 11.45
P/S 1.31
P/FCF 10.31
P/OCF 9.95
P/B 4.04
P/tB N/A
EV/EBITDA 9.64
EPS(TTM)0.68
EY7.61%
EPS(NY)0.78
Fwd EY8.74%
FCF(TTM)0.87
FCFY9.7%
OCF(TTM)0.9
OCFY10.05%
SpS6.83
BVpS2.21
TBVpS-2.31
PEG (NY)0.88
PEG (5Y)0.4
Graham Number5.82
Profitability
Industry RankSector Rank
ROA 3.33%
ROE 12.35%
ROCE 10.76%
ROIC 8.5%
ROICexc 9.42%
ROICexgc 46.29%
OM 9.91%
PM (TTM) 4%
GM 68.33%
FCFM 12.69%
ROA(3y)-6.97%
ROA(5y)-6.18%
ROE(3y)-34.02%
ROE(5y)-29.59%
ROIC(3y)3.98%
ROIC(5y)N/A
ROICexc(3y)4.38%
ROICexc(5y)N/A
ROICexgc(3y)24.58%
ROICexgc(5y)N/A
ROCE(3y)5.03%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1.39%
ROICexc growth 3YN/A
ROICexc growth 5Y4.41%
OM growth 3YN/A
OM growth 5Y3.04%
PM growth 3YN/A
PM growth 5Y23.91%
GM growth 3Y1.86%
GM growth 5Y-1.23%
F-Score8
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF 4.21
Debt/EBITDA 2.78
Cap/Depr 5.45%
Cap/Sales 0.45%
Interest Coverage 2.08
Cash Conversion 72.29%
Profit Quality 317.22%
Current Ratio 1.7
Quick Ratio 1.19
Altman-Z 1.51
F-Score8
WACC10.89%
ROIC/WACC0.78
Cap/Depr(3y)6.77%
Cap/Depr(5y)11.29%
Cap/Sales(3y)0.69%
Cap/Sales(5y)1.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.68%
EPS 3Y61.98%
EPS 5Y32.76%
EPS Q2Q%60%
EPS Next Y14.86%
EPS Next 2Y14.11%
EPS Next 3YN/A
EPS Next 5Y12.25%
Revenue 1Y (TTM)-0.91%
Revenue growth 3Y3.52%
Revenue growth 5Y12.08%
Sales Q2Q%2.77%
Revenue Next Year6.8%
Revenue Next 2Y6.7%
Revenue Next 3Y6.7%
Revenue Next 5Y6.77%
EBIT growth 1Y128.66%
EBIT growth 3YN/A
EBIT growth 5Y15.49%
EBIT Next Year49.52%
EBIT Next 3YN/A
EBIT Next 5Y17.26%
FCF growth 1Y90.83%
FCF growth 3YN/A
FCF growth 5Y1.27%
OCF growth 1Y92.48%
OCF growth 3YN/A
OCF growth 5Y0.79%

BIOVENTUS INC - A / BVS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BIOVENTUS INC - A?

ChartMill assigns a fundamental rating of 5 / 10 to BVS.


What is the valuation status for BVS stock?

ChartMill assigns a valuation rating of 8 / 10 to BIOVENTUS INC - A (BVS). This can be considered as Undervalued.


Can you provide the profitability details for BIOVENTUS INC - A?

BIOVENTUS INC - A (BVS) has a profitability rating of 7 / 10.


What is the valuation of BIOVENTUS INC - A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BIOVENTUS INC - A (BVS) is 13.15 and the Price/Book (PB) ratio is 4.04.


What is the financial health of BIOVENTUS INC - A (BVS) stock?

The financial health rating of BIOVENTUS INC - A (BVS) is 3 / 10.